age
float64 18
102
| sex
stringclasses 2
values | hospdead
int64 0
1
| slos
int64 3
343
| dzgroup
stringclasses 8
values | dzclass
stringclasses 4
values | num.co
int64 0
9
| edu
float64 0
31
⌀ | income
stringclasses 4
values | scoma
float64 0
100
⌀ | charges
float64 1.17k
1.44M
⌀ | totcst
float64 0
633k
⌀ | totmcst
float64 -102.72
711k
⌀ | avtisst
float64 1
83
⌀ | race
stringclasses 5
values | sps
float64 0.2
99.2
⌀ | aps
float64 0
143
⌀ | surv2m
float64 0
0.97
⌀ | surv6m
float64 0
0.95
⌀ | hday
int64 1
148
| diabetes
int64 0
1
| dementia
int64 0
1
| ca
stringclasses 3
values | prg2m
float64 0
1
⌀ | prg6m
float64 0
1
⌀ | dnr
stringclasses 3
values | dnrday
float64 -88
285
⌀ | meanbp
float64 0
195
⌀ | wblc
float64 0
200
⌀ | hrt
float64 0
300
⌀ | resp
float64 0
90
⌀ | temp
float64 31.7
41.7
⌀ | pafi
float64 12
890
⌀ | alb
float64 0.4
29
⌀ | bili
float64 0.1
63
⌀ | crea
float64 0.1
21.5
⌀ | sod
float64 110
181
⌀ | ph
float64 6.83
7.77
⌀ | glucose
float64 0
1.09k
⌀ | bun
float64 1
300
⌀ | urine
float64 0
9k
⌀ | adlp
float64 0
7
⌀ | adls
float64 0
7
⌀ | sfdm2
stringclasses 5
values | adlsc
float64 0
7.07
| event_times
int64 3
2.03k
| event_indicators
int64 0
1
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
73.01599
|
female
| 1
| 19
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 11
|
under $11k
| 41
| 101,109.75
| 64,730.2812
| null | 47
|
white
| 39.5
| 69
| 0.179993
| 0.092987
| 2
| 1
| 0
|
no
| 0.05
| 0.000125
|
dnr after sadm
| 18
| 54
| 12
| 116
| 10
| 38.5
| 182.84375
| 2.199707
| 7.5
| 4.199219
| 133
| 7.339844
| null | null | null | null | 0
|
<2 mo. follow-up
| 0
| 19
| 1
|
71.573
|
male
| 0
| 17
|
COPD
|
COPD/CHF/Cirrhosis
| 2
| null | null | 9
| 33,095.094
| 20,809.25
| null | 22
|
black
| 21.5
| 38
| 0.790894
| 0.664917
| 1
| 0
| 0
|
no
| 0.8
| 0.7
|
no dnr
| 17
| 80
| 7.299805
| 164
| 25
| 36.19531
| 352.8125
| null | 0.599976
| 1
| 137
| 7.599609
| null | null | null | null | null | null | 3.430176
| 807
| 1
|
61.81799
|
male
| 0
| 7
|
CHF
|
COPD/CHF/Cirrhosis
| 1
| 12
|
$11-$25k
| 0
| 16,462.984
| 11,815.6094
| null | 14
|
white
| 25.097656
| 35
| 0.810913
| 0.692993
| 1
| 0
| 0
|
no
| 0.75
| 0.75
|
no dnr
| 7
| 123
| 16.796875
| 134
| 28
| 36.29688
| 195.90625
| null | 0.099991
| 1.099854
| 134
| 7.509766
| null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 762
| 1
|
71.63898
|
female
| 0
| 20
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| null |
$11-$25k
| 0
| 46,942.281
| 31,829.9219
| null | 27.666656
|
white
| 21.199219
| 33
| 0.823975
| 0.763916
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 20
| 61
| 8.199219
| 104
| 12
| 36.19531
| 236.65625
| null | 0.599976
| 2.299805
| 142
| 7.469727
| null | null | null | null | 0
|
no(M2 and SIP pres)
| 0
| 1,422
| 0
|
80.78296
|
female
| 1
| 8
|
Coma
|
Coma
| 0
| null | null | 44
| 16,429.391
| 10,578.7656
| null | 22.5
|
black
| 20.699219
| 31
| 0.429993
| 0.355957
| 1
| 0
| 0
|
no
| 0.1
| 0.001
|
no dnr
| 8
| 119
| 21.597656
| 104
| 30
| 37.89844
| 316.625
| 4.299805
| null | 0.699951
| 142
| 7.429688
| null | null | null | null | 0
|
<2 mo. follow-up
| 0
| 8
| 1
|
64.92499
|
female
| 1
| 4
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| null |
$11-$25k
| 0
| 14,077.844
| 9,115.2031
| null | 37
|
black
| 30.699219
| 57
| 0.690918
| 0.598999
| 1
| 0
| 0
|
no
| 0.1
| 0.001
|
no dnr
| 4
| 60
| 16.097656
| 114
| 27
| 38.5
| 292
| null | 2.899902
| 8.599609
| 128
| 7.399414
| null | null | null | null | null |
<2 mo. follow-up
| 2.262695
| 4
| 1
|
65.19897
|
female
| 0
| 26
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 14
| null | 0
| 78,598.625
| 50,603.0312
| null | 23.25
|
white
| 30.199219
| 47
| 0.615967
| 0.510986
| 13
| 0
| 0
|
no
| null | null |
no dnr
| 26
| 55
| 27.699219
| 124
| 24
| 37.89844
| 140
| 1.899902
| 1.099854
| 0.699951
| 146
| 7.419922
| null | null | null | 4
| 0
|
no(M2 and SIP pres)
| 0
| 244
| 1
|
69.99896
|
female
| 1
| 24
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 11
|
under $11k
| 26
| 110,167.938
| 70,867
| null | 41
|
white
| 35.695313
| 52
| 0.295959
| 0.184998
| 14
| 0
| 0
|
no
| 0.5
| 0.5
|
dnr after sadm
| 22
| 65
| 10.798828
| 136
| 28
| 39.09375
| 60
| 1.5
| 1
| 0.5
| 133
| 7.459961
| null | null | null | 0
| 1
|
<2 mo. follow-up
| 1
| 24
| 1
|
72.849
|
male
| 0
| 27
|
COPD
|
COPD/CHF/Cirrhosis
| 3
| null | null | 0
| 73,245.688
| 49,878.3125
| null | 23.5
|
black
| 27
| 50
| 0.579956
| 0.386963
| 1
| 0
| 1
|
metastatic
| 0.4
| 0.4
|
no dnr
| 27
| 79
| 9.5
| 156
| 40
| 37.59375
| 217.84375
| 2.5
| 0.299988
| 1
| 139
| 7.439453
| null | null | null | null | 5
|
adl>=4 (>=5 if sur)
| 5
| 105
| 1
|
60.41898
|
male
| 1
| 38
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 18
|
>$50k
| 0
| 316,291
| 198,929.125
| null | 35
|
white
| 21.699219
| 17
| 0.784912
| 0.714966
| 80
| 0
| 0
|
no
| null | null |
dnr after sadm
| 37
| 89
| 18
| 100
| 7
| 38.59375
| 276.625
| null | 0.099991
| 1.599854
| 129
| 7.449219
| null | null | null | 0
| 0
|
<2 mo. follow-up
| 0
| 38
| 1
|
43.93198
|
male
| 0
| 9
|
Lung Cancer
|
Cancer
| 1
| 10
| null | 0
| null | null | null | 10.5
|
white
| 13.298828
| 21
| 0.81189
| 0.596924
| 1
| 0
| 0
|
metastatic
| null | null |
no dnr
| 9
| 110
| 2.5
| 104
| 32
| 37.5
| null | 3.899902
| 0.099991
| 0.699951
| 142
| null | null | null | null | 5
| 5
|
SIP>=30
| 5
| 258
| 1
|
81.81799
|
female
| 0
| 7
|
Colon Cancer
|
Cancer
| 1
| 18
| null | 0
| 5,206.25
| 3,978.8965
| null | 8
|
white
| 26.398438
| 22
| 0.594971
| 0.27594
| 1
| 0
| 0
|
metastatic
| 0.5
| 0.1
|
no dnr
| 7
| 115
| 9.599609
| 74
| 22
| 35.79688
| null | 2.599609
| 0.699951
| 0.899902
| 144
| null | null | null | null | null | 6
|
<2 mo. follow-up
| 6
| 17
| 1
|
61.133
|
male
| 0
| 12
|
Lung Cancer
|
Cancer
| 1
| 16
|
$25-$50k
| 0
| 14,348.945
| 9,699.9844
| null | 14.5
|
white
| 25.398438
| 18
| 0.517944
| 0.195984
| 1
| 0
| 0
|
metastatic
| null | null |
no dnr
| 12
| 107
| 9.199219
| 64
| 10
| 36.5
| 371.375
| 2.799805
| 1.399902
| 1
| 136
| 7.399414
| null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 213
| 1
|
57.58197
|
female
| 0
| 22
|
Lung Cancer
|
Cancer
| 1
| 9
| null | 0
| 19,568.297
| 14,059.5469
| null | 7.666664
|
white
| 21.199219
| 19
| 0.636963
| 0.327942
| 1
| 0
| 0
|
metastatic
| 0.6
| 0.2
|
no dnr
| 22
| 78
| 8.298828
| 116
| 20
| 36.59375
| null | null | 0.399963
| 0.599976
| 133
| null | null | null | null | 6
| null |
no(M2 and SIP pres)
| 4.527397
| 84
| 1
|
76.98798
|
male
| 0
| 37
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 12
|
under $11k
| 26
| 103,783.375
| 69,377.75
| null | 28.25
|
white
| 31.597656
| 52
| 0.332947
| 0.217987
| 4
| 0
| 0
|
yes
| 0.5
| 0.5
|
no dnr
| 37
| 110
| 18.699219
| 140
| 40
| 38.39844
| 144.875
| 2.5
| 1
| 1.899902
| 150
| 7.429688
| null | null | null | null | 0
|
adl>=4 (>=5 if sur)
| 0
| 92
| 1
|
74.89697
|
female
| 0
| 9
|
COPD
|
COPD/CHF/Cirrhosis
| 4
| 9
|
$11-$25k
| 0
| 12,089.344
| 7,884.4219
| null | 10.5
|
white
| 22.398438
| 32
| 0.779907
| 0.647949
| 1
| 0
| 0
|
no
| 0.8
| 0.75
|
no dnr
| 9
| 105
| 13.798828
| 120
| 28
| 36.29688
| 311.0625
| null | null | 1.099854
| 138
| 7.40918
| null | null | null | 1
| 1
|
adl>=4 (>=5 if sur)
| 1
| 167
| 1
|
73.20197
|
female
| 0
| 19
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 12
| null | 9
| 38,421.125
| 26,814.0312
| null | 18.333328
|
white
| 25
| 51
| 0.73291
| 0.650879
| 1
| 1
| 0
|
no
| 0.1
| 0.001
|
no dnr
| 19
| 141
| 7.699219
| 50
| 8
| 36.5
| 248
| 1.399902
| 1.099854
| 2.799805
| 158
| 7.429688
| null | null | null | null | 0
| null | 0
| 1,415
| 0
|
28.09299
|
male
| 0
| 5
|
Colon Cancer
|
Cancer
| 1
| 8
| null | 0
| 7,952.297
| 4,544.7227
| null | 11
|
white
| 17.398438
| 8
| 0.870972
| 0.708984
| 1
| 0
| 0
|
metastatic
| 0.8
| 0.5
|
no dnr
| 5
| 77
| 9.298828
| 80
| 20
| 36.59375
| null | 3.199707
| null | 0.899902
| 139
| null | null | null | null | 0
| 1
|
adl>=4 (>=5 if sur)
| 1
| 180
| 1
|
60.15298
|
male
| 0
| 14
|
Lung Cancer
|
Cancer
| 1
| 14
|
$11-$25k
| 0
| 17,149.938
| 11,558.3047
| null | 8.333328
|
white
| 10.798828
| 9
| 0.81897
| 0.609985
| 1
| 0
| 0
|
metastatic
| 0.5
| 0.4
|
no dnr
| 14
| 83
| 6.599609
| 86
| 20
| 38.39844
| 224.96875
| 3.699707
| 0.399963
| 0.699951
| 139
| 7.419922
| null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 205
| 1
|
41.13898
|
male
| 0
| 5
|
Lung Cancer
|
Cancer
| 1
| 8
|
under $11k
| 0
| 4,330.859
| 2,927.4707
| null | 4
|
white
| 11.398438
| 5
| 0.840942
| 0.649902
| 1
| 0
| 0
|
metastatic
| 0.8
| 0.5
|
no dnr
| 5
| 87
| null | 80
| 24
| 36.69531
| null | 3.799805
| 0.199982
| 0.599976
| 141
| null | null | null | null | 0
| null | null | 0.4948
| 89
| 1
|
64.71497
|
male
| 0
| 6
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 2
| 12
|
$25-$50k
| 0
| 4,430.047
| 3,109.2207
| null | 7
|
white
| 17.097656
| 20
| 0.806885
| 0.688965
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 6
| 70
| 10.398438
| 70
| 20
| 36.39844
| null | 2.599609
| 2.199707
| 0.899902
| 135
| null | null | null | null | 4
| 3
|
no(M2 and SIP pres)
| 3
| 1,029
| 1
|
30.33499
|
female
| 1
| 10
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 12
|
>$50k
| 61
| null | null | null | 41.5
|
white
| 32.09375
| 58
| 0.546997
| 0.43396
| 4
| 0
| 0
|
no
| null | null |
dnr after sadm
| 9
| 140
| 6.5
| 156
| 26
| 38.59375
| 82.21875
| null | 2.699707
| 0.799927
| 145
| 7.269531
| null | null | null | null | null |
<2 mo. follow-up
| 2.725098
| 10
| 1
|
53.22098
|
female
| 1
| 109
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 10
|
$25-$50k
| 0
| 530,330
| 338,627.25
| null | 47
|
white
| 23.199219
| 44
| 0.802979
| 0.737915
| 14
| 1
| 0
|
no
| 0.75
| 0.75
|
dnr after sadm
| 104
| 75
| 27.699219
| 96
| 12
| 37.89844
| 272
| null | 2.5
| 2.199707
| 134
| 7.439453
| null | null | null | null | 0
| null | 0
| 109
| 1
|
78.10498
|
female
| 1
| 30
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 2
|
under $11k
| 0
| 73,564.562
| 49,620.125
| null | 15.25
|
white
| 27.296875
| 45
| 0.615967
| 0.510986
| 11
| 0
| 0
|
no
| 0.7
| 0.5
|
no dnr
| 30
| 63
| 18.5
| 120
| 28
| 37.39844
| 293.3125
| null | null | 2.5
| 135
| 7.379883
| null | null | null | null | 7
|
<2 mo. follow-up
| 7
| 30
| 1
|
69.04297
|
female
| 1
| 18
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 7
| null | 26
| 86,513.75
| 56,714.1562
| null | 48.666657
|
white
| 29.199219
| 63
| 0.598999
| 0.491943
| 1
| 0
| 0
|
no
| 0.1
| 0.001
|
dnr after sadm
| 5
| 62
| 13.798828
| 66
| 39
| 36.59375
| 147.5
| 2.5
| 2.5
| 2.099609
| 145
| 7.169922
| null | null | null | null | 6
|
<2 mo. follow-up
| 6
| 18
| 1
|
26.519
|
female
| 0
| 17
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 12
|
under $11k
| 0
| 32,705.891
| 21,617.4688
| null | 16.333328
|
black
| 34.09375
| 84
| 0.778931
| 0.707886
| 2
| 1
| 0
|
no
| null | null |
no dnr
| 17
| 145
| 49.695313
| 166
| 56
| 38.89844
| 132.625
| 1.5
| 2.799805
| 1.099854
| 132
| 7.429688
| null | null | null | 1
| 1
|
no(M2 and SIP pres)
| 1
| 1,410
| 0
|
64.52295
|
female
| 0
| 15
|
COPD
|
COPD/CHF/Cirrhosis
| 2
| 18
|
>$50k
| 0
| 14,548.125
| 9,736.9297
| null | 13.333328
|
white
| 11.798828
| 17
| 0.928955
| 0.878906
| 1
| 0
| 0
|
no
| 0.99
| 0.95
|
no dnr
| 15
| 73
| 3.899902
| 105
| 20
| 36.89844
| 260.8125
| 4.399414
| 0.299988
| 0.699951
| 141
| 7.389648
| null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 1,409
| 1
|
71.79999
|
male
| 0
| 8
|
COPD
|
COPD/CHF/Cirrhosis
| 1
| 6
| null | 0
| 6,795.148
| 4,689
| null | 8.5
|
white
| 25.199219
| 32
| 0.755981
| 0.613892
| 1
| 0
| 0
|
no
| 0.75
| 0.6
|
no dnr
| 8
| 100
| 9.398438
| 110
| 22
| 36.29688
| 156
| 3.199707
| 0.099991
| 0.699951
| 141
| 7.359375
| null | null | null | 1
| 0
| null | 0
| 1,409
| 0
|
64.10095
|
male
| 1
| 8
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 15
|
$11-$25k
| 0
| 45,839.344
| 27,262.6094
| null | 39.5
|
white
| 30.5
| 40
| 0.646973
| 0.546997
| 5
| 1
| 0
|
no
| 0.1
| 0.001
|
dnr after sadm
| 8
| 65
| 11.099609
| 64
| 24
| 35.29688
| 352
| null | null | 5.299805
| 128
| 7.339844
| null | null | null | null | 0
|
<2 mo. follow-up
| 0
| 8
| 1
|
74.36798
|
female
| 0
| 12
|
MOSF w/Malig
|
ARF/MOSF
| 1
| null |
under $11k
| 0
| 15,472.344
| 10,627.0859
| null | 19.5
|
black
| 21.699219
| 39
| 0.730957
| 0.647949
| 1
| 0
| 0
|
yes
| 0.95
| 0.9
|
no dnr
| 12
| 57
| 11.099609
| 70
| 28
| 36.69531
| 412
| 2.799805
| 0.899902
| 1.699951
| 143
| 7.339844
| null | null | null | null | null |
no(M2 and SIP pres)
| 2.503906
| 1,409
| 0
|
81.10297
|
male
| 0
| 21
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 1
| null | null | 0
| 20,806.703
| 16,225.6094
| null | 13.333328
|
white
| 16.898438
| 39
| 0.708984
| 0.54895
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 21
| 100
| 3.799805
| 72
| 18
| 36.59375
| 228.5625
| 2.899902
| 2.099609
| 1.399902
| 148
| 7.449219
| null | null | null | null | null | null | 2.790527
| 615
| 1
|
56.64099
|
male
| 0
| 18
|
Lung Cancer
|
Cancer
| 1
| 12
| null | 0
| 21,573.094
| 14,371.5078
| null | 10
|
white
| 28.699219
| 17
| 0.439941
| 0.130981
| 1
| 0
| 0
|
metastatic
| 0.5
| 0.25
|
dnr after sadm
| 14
| 84
| 18
| 126
| 22
| 37
| 319
| 2.899902
| null | 0.699951
| 141
| 7.479492
| null | null | null | 0
| 0
| null | 0
| 60
| 1
|
47.21997
|
male
| 0
| 7
|
Colon Cancer
|
Cancer
| 1
| 16
|
>$50k
| 0
| 7,890.449
| 5,285.582
| null | 11
|
white
| 8.798828
| 7
| 0.917969
| 0.809937
| 1
| 0
| 0
|
metastatic
| 0.9
| 0.6
|
no dnr
| 7
| 80
| 4.299805
| 100
| 22
| 38.59375
| null | 4
| 0.299988
| 0.899902
| 142
| null | null | null | null | null | 0
|
no(M2 and SIP pres)
| 0
| 400
| 1
|
66.42297
|
female
| 0
| 11
|
Colon Cancer
|
Cancer
| 1
| 12
|
$11-$25k
| 0
| 6,924.148
| 5,220.8633
| null | 8.5
|
white
| 18.199219
| 13
| 0.797974
| 0.570923
| 1
| 0
| 0
|
metastatic
| null | null |
no dnr
| 11
| 87
| 6.299805
| 100
| 28
| 37.79688
| 447.5625
| null | null | 0.599976
| 139
| 7.569336
| null | null | null | 1
| 1
|
no(M2 and SIP pres)
| 1
| 109
| 1
|
61.07599
|
female
| 0
| 5
|
Colon Cancer
|
Cancer
| 1
| 12
|
under $11k
| 0
| 5,752.047
| 3,460.1836
| null | 10
|
white
| 12.199219
| 11
| 0.876953
| 0.7229
| 1
| 0
| 0
|
metastatic
| 0.9
| 0.5
|
no dnr
| 5
| 113
| 5.5
| 70
| 24
| 35.69531
| null | 3.899902
| 0.199982
| 0.699951
| 141
| null | null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 134
| 1
|
47.35898
|
male
| 1
| 5
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 14
| null | 0
| 31,451.266
| 18,780.1094
| null | 49
|
black
| 27.097656
| 51
| 0.822998
| 0.762939
| 1
| 0
| 0
|
no
| 0.5
| 0.5
|
no dnr
| 5
| 55
| 13.099609
| 124
| 30
| 40.69531
| 300
| 1.299805
| 0.099991
| 0.799927
| 136
| 7.439453
| null | null | null | null | null |
<2 mo. follow-up
| 1.888184
| 5
| 1
|
61.65598
|
female
| 1
| 10
|
MOSF w/Malig
|
ARF/MOSF
| 1
| 13
|
>$50k
| 44
| 68,828.75
| 42,445.4375
| null | 47.5
|
white
| 41.398438
| 87
| 0.028999
| 0.007
| 8
| 0
| 0
|
yes
| null | null |
dnr after sadm
| 9
| 110
| 0.199982
| 120
| 42
| 38.5
| 248
| null | 8.798828
| 2.899902
| 140
| 7.359375
| null | null | null | null | 0
|
<2 mo. follow-up
| 0
| 10
| 1
|
64.60797
|
female
| 0
| 5
|
Colon Cancer
|
Cancer
| 1
| 8
| null | 0
| 5,229.797
| 3,796.2519
| null | 7
|
black
| 19
| 21
| 0.789917
| 0.556885
| 1
| 0
| 0
|
metastatic
| null | null |
no dnr
| 5
| 81
| 10.599609
| 64
| 28
| 36.39844
| 352.375
| null | 1.399902
| 1.399902
| 139
| 7.5
| null | null | null | 0
| null |
no(M2 and SIP pres)
| 0.4948
| 93
| 1
|
80.37
|
male
| 1
| 87
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| null |
under $11k
| 0
| null | null | null | 39.25
|
white
| 43.898438
| 96
| 0.233978
| 0.132996
| 1
| 0
| 0
|
no
| 0.1
| 0.001
|
dnr after sadm
| 15
| 49
| 29.699219
| 80
| 36
| 34
| 146.65625
| 1.299805
| 2.699707
| 2.299805
| 153
| 7.469727
| null | null | null | null | null | null | 2.986816
| 87
| 1
|
70.74298
|
female
| 0
| 21
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 13
| null | 26
| 93,786.312
| 58,329.4062
| null | 27
|
hispanic
| 30.398438
| 45
| 0.469971
| 0.350952
| 8
| 0
| 0
|
no
| 0.95
| 0.95
|
no dnr
| 21
| 62
| 12.798828
| 110
| 8
| 36.19531
| 383.3125
| 2.899902
| 5.299805
| 2.299805
| 147
| 7.419922
| null | null | null | null | 7
| null | 7
| 1,397
| 0
|
45.84497
|
male
| 0
| 10
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 16
|
$25-$50k
| 0
| 17,144.141
| 12,614.4609
| null | 18
|
black
| 18
| 22
| 0.912964
| 0.881958
| 1
| 0
| 0
|
no
| 0.9
| 0.9
|
no dnr
| 10
| 101
| 18.699219
| 104
| 31
| 37.89844
| 246.65625
| 2.699707
| 0.199982
| 1
| 139
| 7.399414
| null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 1,396
| 0
|
52.22998
|
female
| 1
| 4
|
Lung Cancer
|
Cancer
| 1
| 12
|
under $11k
| 100
| 6,356.336
| 4,161.4805
| null | 28
|
black
| 74.09375
| 72
| 0
| 0
| 1
| 0
| 0
|
metastatic
| 0.1
| 0.001
|
no dnr
| 4
| 0
| 18.5
| 0
| 0
| 38.69531
| 223.78125
| null | null | 0.699951
| 126
| 7.439453
| null | null | null | null | null |
<2 mo. follow-up
| 2.356934
| 4
| 1
|
47.16998
|
male
| 0
| 90
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| null | null | 0
| 163,735.875
| 111,310.188
| null | 20.5
|
black
| 20.097656
| 18
| 0.894897
| 0.85791
| 1
| 0
| 0
|
no
| 0.65
| 0.65
|
no dnr
| 90
| 137
| 9.699219
| 136
| 12
| 37.59375
| 360
| null | 0.899902
| 1.199951
| 134
| 7.439453
| null | null | null | null | null | null | 1.798096
| 1,396
| 0
|
53.18799
|
male
| 0
| 7
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| 12
| null | 0
| 15,708.242
| 11,773.0078
| null | 7.5
|
white
| 15.699219
| 17
| 0.921997
| 0.86792
| 1
| 0
| 0
|
no
| 0.95
| 0.9
|
no dnr
| 7
| 82
| 5.799805
| 80
| 20
| 36.19531
| 432
| null | 0.599976
| 1.5
| 141
| 7.459961
| null | null | null | 2
| 1
|
no(M2 and SIP pres)
| 1
| 1,396
| 0
|
78.09198
|
female
| 0
| 6
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 7
|
under $11k
| 0
| 11,205.695
| 7,529.1602
| null | 29
|
black
| 25
| 42
| 0.74292
| 0.594971
| 1
| 1
| 0
|
no
| 0.7
| 0.7
|
no dnr
| 6
| 73
| 11.298828
| 130
| 25
| 36.89844
| 372
| null | null | 1.899902
| 141
| 7.459961
| null | null | null | null | 1
|
no(M2 and SIP pres)
| 1
| 303
| 1
|
70.47797
|
male
| 0
| 6
|
Colon Cancer
|
Cancer
| 1
| null | null | 0
| 6,633.75
| 4,108.207
| null | 9
|
black
| 24.898438
| 29
| 0.664917
| 0.363953
| 1
| 1
| 0
|
metastatic
| 0.7
| 0.1
|
no dnr
| 6
| 113
| 10.699219
| 80
| 28
| 36.39844
| null | 2.899902
| 2.399902
| 0.899902
| 138
| null | null | null | null | 0
| 0
|
<2 mo. follow-up
| 0
| 51
| 1
|
61.89999
|
male
| 1
| 106
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 12
|
under $11k
| 0
| null | null | null | 23
|
white
| 38.296875
| 52
| 0.387939
| 0.269958
| 41
| 0
| 0
|
no
| 0.5
| 0.5
|
dnr after sadm
| 9
| 81
| 14.199219
| 124
| 33
| 35.09375
| 193.3125
| 3.399902
| 1.5
| 4.399414
| 130
| 7.479492
| null | null | null | null | 1
|
adl>=4 (>=5 if sur)
| 1
| 106
| 1
|
57.47299
|
female
| 0
| 18
|
Colon Cancer
|
Cancer
| 1
| 12
| null | 0
| 17,594.547
| 11,910.8281
| null | 7.666664
|
white
| 13.298828
| 15
| 0.871948
| 0.710938
| 1
| 0
| 0
|
metastatic
| 1
| 1
|
no dnr
| 18
| 74
| 10.5
| 84
| 20
| 37.59375
| null | null | 0.299988
| 0.899902
| 140
| null | null | null | null | 0
| 3
|
no(M2 and SIP pres)
| 3
| 222
| 1
|
39.93198
|
male
| 0
| 45
|
Coma
|
Coma
| 1
| 8
|
under $11k
| 44
| 93,780.188
| 60,261.5938
| null | 35.25
|
white
| 17.699219
| 17
| 0.812988
| 0.775879
| 1
| 0
| 0
|
no
| 0.3
| 0.2
|
dnr after sadm
| 10
| 72
| 16.296875
| 70
| 30
| 36.5
| 242.84375
| null | 0.199982
| 0.799927
| 144
| 7.459961
| null | null | null | null | 0
|
adl>=4 (>=5 if sur)
| 0
| 1,393
| 0
|
48.077
|
female
| 0
| 10
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 2
| 12
|
$11-$25k
| 0
| 9,770.945
| 6,952.6992
| null | 8.5
|
white
| 16.597656
| 27
| 0.882935
| 0.804932
| 1
| 0
| 0
|
no
| 0.8
| 0.7
|
no dnr
| 10
| 77
| 6
| 74
| 20
| 37.79688
| null | 2.299805
| 4.5
| 0.799927
| 136
| null | null | null | null | 7
| 7
|
no(M2 and SIP pres)
| 7
| 1,392
| 0
|
60.59399
|
female
| 1
| 7
|
MOSF w/Malig
|
ARF/MOSF
| 0
| 3
| null | 100
| 60,863.469
| 40,220.8438
| null | 22.5
|
white
| 48
| 68
| 0
| 0
| 26
| 0
| 0
|
yes
| 0
| 0
|
dnr after sadm
| 2
| 43
| 0.899902
| 114
| 12
| 40
| 298
| null | 5
| 1.699951
| 129
| 7.40918
| null | null | null | null | 3
|
<2 mo. follow-up
| 3
| 7
| 1
|
56.35898
|
female
| 0
| 16
|
MOSF w/Malig
|
ARF/MOSF
| 1
| 14
|
$25-$50k
| 0
| 28,776.484
| 19,103.0938
| null | 16.666656
|
white
| 31
| 73
| 0.43396
| 0.313965
| 2
| 0
| 0
|
metastatic
| 0.6
| 0.5
|
no dnr
| 16
| 60
| 6.699219
| 122
| 40
| 38.5
| 248
| 2.399902
| 2.599609
| 2.199707
| 127
| 7.399414
| null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 1,391
| 0
|
84.69299
|
male
| 1
| 44
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 16
| null | 44
| 94,629
| 66,053.125
| null | 20
|
black
| 28.097656
| 56
| 0.311951
| 0.198975
| 23
| 1
| 0
|
no
| 0.5
| 0.125
|
dnr after sadm
| 2
| 111
| 12.398438
| 60
| 3
| 36.5
| 217.125
| 2.899902
| 0.799927
| 3.099609
| 142
| 7.40918
| null | null | null | null | 5
|
<2 mo. follow-up
| 5
| 44
| 1
|
67.07196
|
male
| 0
| 4
|
Lung Cancer
|
Cancer
| 1
| 16
|
$25-$50k
| 0
| 1,635.75
| 1,285.1836
| null | 7
|
white
| 14
| 8
| 0.758911
| 0.504883
| 1
| 0
| 0
|
metastatic
| 0.8
| 0.6
|
no dnr
| 4
| 90
| 6.899414
| 72
| 22
| 36.69531
| null | null | 1.299805
| 1
| 141
| null | null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 94
| 1
|
55.75897
|
female
| 0
| 12
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 12
|
under $11k
| 0
| 54,305.781
| 32,730.2031
| null | 27.5
|
white
| 21.097656
| 21
| 0.85791
| 0.80896
| 2
| 0
| 0
|
no
| 0.99
| 0.99
|
no dnr
| 12
| 63
| 11.599609
| 114
| 6
| 38.09375
| 226.65625
| null | 1.699951
| 0.699951
| 144
| 7.359375
| null | null | null | 0
| 0
|
SIP>=30
| 0
| 1,390
| 0
|
67.77295
|
female
| 1
| 37
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3
| 11
|
under $11k
| 44
| 60,532.938
| 38,475
| null | 21
|
white
| 26.296875
| 36
| 0.600952
| 0.492981
| 1
| 1
| 0
|
no
| null | null |
no dnr
| 37
| 94
| 22
| 130
| 28
| 38.5
| 186.65625
| null | 0.799927
| 1.599854
| 135
| 7.329102
| null | null | null | 5
| 6
|
<2 mo. follow-up
| 6
| 37
| 1
|
69.95996
|
female
| 0
| 3
|
CHF
|
COPD/CHF/Cirrhosis
| 4
| 3
|
under $11k
| 0
| 1,672.449
| 1,343.5801
| null | 7
|
black
| 16.796875
| 25
| 0.878906
| 0.79895
| 1
| 1
| 0
|
no
| 0.9
| 0.5
|
no dnr
| 3
| 80
| 4.299805
| 64
| 28
| 36.5
| 366.625
| null | null | 1.299805
| 140
| 7.40918
| null | null | null | null | null |
no(M2 and SIP pres)
| 2.993164
| 77
| 1
|
65.39398
|
male
| 1
| 3
|
Coma
|
Coma
| 1
| 7
|
under $11k
| 100
| 14,855.242
| 9,849.8047
| null | 41
|
black
| 75.390625
| 80
| 0
| 0
| 1
| 0
| 0
|
no
| 0.05
| 0.000125
|
no dnr
| 3
| 0
| 9.398438
| 0
| 14
| 35.09375
| 187.5
| 1.799805
| null | 4.399414
| 143
| 7.329102
| null | null | null | null | 0
|
<2 mo. follow-up
| 0
| 3
| 1
|
78.92694
|
male
| 0
| 35
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| null | null | 37
| 59,747.969
| 40,751.8125
| null | 22.25
|
black
| 29.199219
| 62
| 0.434998
| 0.315979
| 3
| 0
| 0
|
no
| null | null |
dnr after sadm
| 6
| 65
| 15
| 64
| 26
| 36.69531
| 137.5
| 2.199707
| 0.299988
| 10.898438
| 129
| 7.399414
| null | null | null | null | null | null | 3.630371
| 1,387
| 0
|
76.65399
|
female
| 0
| 7
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| null | null | 0
| 4,969.898
| 3,531.9766
| null | 10.5
|
white
| 21.097656
| 22
| 0.809937
| 0.691895
| 1
| 0
| 0
|
no
| 0.7
| 0.5
|
no dnr
| 7
| 71
| 11.699219
| 56
| 16
| 35.09375
| 400
| null | null | 1.199951
| 137
| 7.5
| null | null | null | null | 0
|
<2 mo. follow-up
| 0
| 33
| 1
|
57.05698
|
male
| 1
| 6
|
Lung Cancer
|
Cancer
| 1
| null | null | 0
| 8,189.148
| 5,071.8945
| null | 18
|
white
| 27.898438
| 20
| 0.461975
| 0.14798
| 1
| 0
| 0
|
metastatic
| null | null |
dnr after sadm
| 2
| 83
| 6.099609
| 114
| 28
| 36.39844
| 356.625
| 2.799805
| 0.299988
| 0.799927
| 139
| 7.299805
| null | null | null | null | null |
<2 mo. follow-up
| 2.410645
| 6
| 1
|
48.51999
|
male
| 0
| 81
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 12
|
$25-$50k
| 0
| 322,828.75
| 205,589.25
| null | 48
|
white
| 34.398438
| 57
| 0.610962
| 0.504883
| 13
| 0
| 0
|
no
| null | null |
no dnr
| 81
| 54
| 15
| 124
| 28
| 39.39844
| 190
| 2.299805
| 1
| 2.399902
| 150
| 7.419922
| null | null | null | null | 7
|
adl>=4 (>=5 if sur)
| 7
| 1,385
| 0
|
61.71899
|
female
| 0
| 11
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 12
|
$25-$50k
| 0
| 31,584.484
| 20,443.0781
| null | 19.5
|
white
| 23.699219
| 14
| 0.767944
| 0.69397
| 11
| 0
| 0
|
no
| null | null |
no dnr
| 11
| 101
| 11
| 124
| 23
| 36.29688
| 316.3125
| 2.899902
| 0.5
| 0.5
| 141
| 7.389648
| null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 577
| 1
|
55.36798
|
female
| 0
| 28
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| 13
|
under $11k
| 0
| 75,277.938
| 46,333.0625
| null | 29.5
|
white
| 19.796875
| 19
| 0.873901
| 0.790894
| 3
| 1
| 0
|
no
| 0.85
| 0.8
|
no dnr
| 28
| 82
| 5.899414
| 110
| 26
| 39
| null | null | null | 0.699951
| 137
| null | null | null | null | null | 1
|
adl>=4 (>=5 if sur)
| 1
| 108
| 1
|
50.17697
|
female
| 0
| 30
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 16
|
$11-$25k
| 41
| 94,015.438
| 60,084.4062
| null | 26
|
black
| 19.796875
| 20
| 0.776978
| 0.704956
| 5
| 0
| 0
|
no
| 0.6
| 0.5
|
no dnr
| 30
| 130
| 20.199219
| 114
| 24
| 38.39844
| 250
| 3.899902
| null | 0.799927
| 137
| 7.419922
| null | null | null | null | 0
|
no(M2 and SIP pres)
| 0
| 1,382
| 0
|
34.15698
|
female
| 0
| 13
|
CHF
|
COPD/CHF/Cirrhosis
| 0
| 18
|
>$50k
| 0
| 31,092.484
| 21,191.4688
| null | 31
|
white
| 22.699219
| 20
| 0.910889
| 0.849976
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 13
| 112
| 8.298828
| 110
| 26
| 36.79688
| 266.625
| 2.899902
| 0.899902
| 1
| 136
| 7.469727
| null | null | null | 1
| 1
| null | 1
| 1,382
| 0
|
50.62299
|
female
| 0
| 23
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 10
|
$11-$25k
| 0
| 52,901.719
| 36,472.8125
| null | 27
|
white
| 18.398438
| 25
| 0.901978
| 0.866943
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 23
| 114
| 7.199219
| 104
| 30
| 38.5
| 256.625
| 2
| 1.199951
| 0.599976
| 140
| 7.5
| null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 1,382
| 0
|
69.81195
|
male
| 1
| 7
|
MOSF w/Malig
|
ARF/MOSF
| 1
| 0
|
under $11k
| 0
| 58,640.125
| 36,645.7812
| null | 41.5
|
white
| 34.695313
| 64
| 0.297974
| 0.186981
| 15
| 0
| 0
|
yes
| null | null |
dnr after sadm
| 6
| 109
| 0.5
| 174
| 29
| 40.19531
| 166
| null | 0.599976
| 0.799927
| 138
| 7.469727
| null | null | null | null | 0
|
<2 mo. follow-up
| 0
| 7
| 1
|
85.53894
|
male
| 0
| 21
|
MOSF w/Malig
|
ARF/MOSF
| 1
| null | null | 9
| 28,541.031
| 19,546.8594
| null | 12.333328
|
black
| 23.796875
| 24
| 0.56189
| 0.449951
| 7
| 0
| 0
|
yes
| null | null |
no dnr
| 21
| 93
| 11
| 80
| 26
| 36
| 146.9375
| null | 0.199982
| 1.299805
| 146
| 7.399414
| null | null | null | 4
| 2
|
no(M2 and SIP pres)
| 2
| 1,379
| 0
|
53.18799
|
male
| 0
| 101
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 11
| null | 0
| 284,256.75
| 193,046.75
| null | 39
|
white
| 40.296875
| 43
| 0.526978
| 0.411987
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 101
| 39
| 16
| 124
| 10
| 36.5
| 165.6875
| 2.699707
| null | 1.399902
| 148
| 7.449219
| null | null | null | null | 2
|
adl>=4 (>=5 if sur)
| 2
| 285
| 1
|
43.39499
|
female
| 0
| 17
|
MOSF w/Malig
|
ARF/MOSF
| 1
| 12
|
$25-$50k
| 9
| 68,084.312
| 44,917.2812
| null | 23.666656
|
white
| 28.398438
| 43
| 0.593994
| 0.485962
| 1
| 0
| 0
|
yes
| null | null |
no dnr
| 17
| 107
| 3
| 130
| 46
| 36
| 304.75
| 2.099609
| null | 1
| 140
| 7.449219
| null | null | null | null | 1
|
no(M2 and SIP pres)
| 1
| 1,379
| 0
|
65.90594
|
male
| 1
| 5
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 1
| null | null | 0
| 3,840.35
| 2,740.5918
| null | 13
|
white
| 36.195313
| 70
| 0.352966
| 0.162994
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 5
| 73
| 8.099609
| 76
| 22
| 35.29688
| 457.125
| 1.799805
| 26.296875
| 3.5
| 130
| 7.419922
| null | null | null | 5
| null |
<2 mo. follow-up
| 3.855299
| 5
| 1
|
54.42798
|
male
| 0
| 46
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 12
|
under $11k
| 26
| 149,515
| 97,945.25
| null | 24.5
|
black
| 26.097656
| 44
| 0.655884
| 0.556885
| 18
| 1
| 0
|
no
| 0.9
| 0.8
|
no dnr
| 46
| 102
| 16.296875
| 104
| 28
| 38.09375
| 150
| 1.699951
| null | 1.699951
| 146
| 7.389648
| null | null | null | null | 7
|
no(M2 and SIP pres)
| 7
| 1,378
| 0
|
54.754
|
female
| 0
| 19
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| 10
|
$25-$50k
| 0
| 45,468.906
| 28,772.2188
| null | 25
|
black
| 18.597656
| 18
| 0.898926
| 0.830933
| 1
| 0
| 0
|
no
| null | null |
dnr after sadm
| 5
| 83
| 4.599609
| 74
| 36
| 36.09375
| 290
| null | null | 0.799927
| 134
| 7.479492
| null | null | null | null | 2
|
no(M2 and SIP pres)
| 2
| 1,378
| 0
|
79.55396
|
female
| 1
| 12
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 12
|
$11-$25k
| 0
| 57,881.625
| 38,559.0312
| null | 28.5
|
white
| 31.796875
| 50
| 0.505981
| 0.388977
| 7
| 0
| 0
|
no
| 0.1
| 0.001
|
dnr after sadm
| 6
| 115
| 10.898438
| 180
| 36
| 36.79688
| 126.65625
| null | null | 1.699951
| 138
| 7.439453
| null | null | null | null | 0
|
<2 mo. follow-up
| 0
| 12
| 1
|
52.586
|
male
| 1
| 39
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 12
|
$25-$50k
| 9
| 156,079.125
| 99,411.4375
| null | 17.75
|
white
| 30.199219
| 56
| 0.655884
| 0.556885
| 10
| 0
| 0
|
no
| 0.95
| 0.95
|
no dnr
| 39
| 60
| 28.5
| 156
| 32
| 36
| 476.1875
| 2.5
| 1.799805
| 2.199707
| 146
| 7.439453
| null | null | null | null | 0
|
<2 mo. follow-up
| 0
| 39
| 1
|
89.35199
|
female
| 0
| 18
|
COPD
|
COPD/CHF/Cirrhosis
| 3
| 14
|
$25-$50k
| 0
| 26,882.234
| 17,633.8281
| null | 20.666656
|
white
| 27.199219
| 37
| 0.544922
| 0.346985
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 18
| 103
| 11.398438
| 124
| 28
| 36.19531
| 157.125
| null | 0.799927
| 1.299805
| 140
| 7.439453
| null | null | null | null | 4
|
no(M2 and SIP pres)
| 4
| 1,377
| 0
|
62.37598
|
male
| 1
| 28
|
MOSF w/Malig
|
ARF/MOSF
| 1
| 19
|
>$50k
| 0
| 88,716.75
| 55,218.75
| null | 23.5
|
white
| 29
| 49
| 0.492981
| 0.375
| 10
| 0
| 0
|
yes
| null | null |
dnr after sadm
| 22
| 61
| 0.099991
| 126
| 30
| 38.79688
| 256
| null | 0.799927
| 0.899902
| 138
| 7.479492
| null | null | null | 0
| 0
|
<2 mo. follow-up
| 0
| 28
| 1
|
72.45197
|
male
| 0
| 7
|
Lung Cancer
|
Cancer
| 1
| 12
|
$11-$25k
| 0
| 14,996.648
| 8,643.25
| null | 14.5
|
white
| 40.59375
| 40
| 0.080994
| 0.002
| 1
| 0
| 0
|
metastatic
| null | null |
no dnr
| 7
| 57
| 17.199219
| 146
| 24
| 35.69531
| null | 2.099609
| 0.199982
| 0.899902
| 137
| null | null | null | null | null | 2
|
<2 mo. follow-up
| 2
| 52
| 1
|
44.70599
|
male
| 0
| 14
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 13
|
>$50k
| 0
| 54,420.094
| 32,991.3438
| null | 32
|
white
| 26
| 34
| 0.831909
| 0.775879
| 2
| 0
| 0
|
no
| 0.99
| 0.99
|
no dnr
| 14
| 67
| 12.5
| 74
| 5
| 36.59375
| 146.65625
| null | null | 1.399902
| 136
| 7.429688
| null | null | null | null | 0
|
no(M2 and SIP pres)
| 0
| 1,375
| 0
|
84.95294
|
female
| 1
| 5
|
MOSF w/Malig
|
ARF/MOSF
| 2
| 16
|
$11-$25k
| 44
| 43,507.656
| 27,881.4688
| null | 31
|
white
| 49.296875
| 96
| 0
| 0
| 17
| 0
| 0
|
yes
| null | null |
dnr after sadm
| 4
| 51
| 0.199982
| 140
| 27
| 39.09375
| 128.3125
| 2.599609
| 3.299805
| 3.299805
| 141
| 7.5
| null | null | null | null | 0
|
<2 mo. follow-up
| 0
| 5
| 1
|
40.82999
|
male
| 0
| 12
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 4
| null | null | 9
| 10,073.695
| 7,346.5
| null | 9
|
black
| 27.199219
| 40
| 0.763916
| 0.625
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 12
| 83
| 13
| 108
| 20
| 36.29688
| 323.75
| 1.099854
| 13.5
| 1.199951
| 146
| 7.469727
| null | null | null | null | null | null | 3.671387
| 73
| 1
|
72.97998
|
male
| 0
| 19
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| null | null | 0
| 37,242.969
| 24,578.5469
| null | 22
|
black
| 33.695313
| 37
| 0.575928
| 0.465942
| 1
| 0
| 0
|
no
| 0.9
| 0.88
|
no dnr
| 19
| 87
| 10.699219
| 146
| 33
| 37
| 205.6875
| 3.099609
| 0.5
| 1.699951
| 121
| 7.389648
| null | null | null | null | null | null | 2.907715
| 1,365
| 0
|
63.74799
|
female
| 1
| 32
|
MOSF w/Malig
|
ARF/MOSF
| 1
| 12
| null | 0
| null | null | null | 21.25
|
white
| 33.5
| 63
| 0.278992
| 0.169983
| 8
| 0
| 0
|
metastatic
| 0.95
| 0.85
|
dnr after sadm
| 30
| 130
| 10.898438
| 136
| 32
| 39.19531
| 193.3125
| 2.199707
| 8.599609
| 1.899902
| 137
| 7.429688
| null | null | null | null | 0
|
<2 mo. follow-up
| 0
| 32
| 1
|
57.35498
|
male
| 0
| 39
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 10
|
under $11k
| 37
| 104,662.625
| 67,909.6875
| null | 30.5
|
black
| 32.195313
| 64
| 0.542969
| 0.428955
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 39
| 63
| 10.798828
| 126
| 24
| 38.89844
| 224
| 1.699951
| 16.097656
| 1.899902
| 149
| 7.389648
| null | null | null | null | null |
SIP>=30
| 2.34375
| 1,364
| 0
|
56.40198
|
male
| 1
| 15
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 3
| 14
|
>$50k
| 0
| 37,778.875
| 24,318.8906
| null | 27
|
white
| 20.699219
| 46
| 0.799927
| 0.677979
| 1
| 0
| 0
|
no
| 0.5
| 0.7
|
dnr after sadm
| 15
| 63
| 6.299805
| 68
| 26
| 36.39844
| 210
| 2.199707
| 5.099609
| 1
| 142
| 7.449219
| null | null | null | 0
| 0
|
<2 mo. follow-up
| 0
| 15
| 1
|
81.07599
|
male
| 0
| 27
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 7
|
under $11k
| 9
| 40,158.719
| 27,819.7812
| null | 14.5
|
white
| 32.695313
| 41
| 0.429993
| 0.310974
| 6
| 0
| 0
|
no
| null | null |
dnr after sadm
| 9
| 47
| 12.5
| 42
| 25
| 36.29688
| 190
| 2.899902
| null | 1.199951
| 139
| 7.469727
| null | null | null | null | 4
|
<2 mo. follow-up
| 4
| 30
| 1
|
83.90997
|
female
| 0
| 9
|
COPD
|
COPD/CHF/Cirrhosis
| 1
| 14
|
$11-$25k
| 0
| 7,561.797
| 5,520.7109
| null | 14
|
white
| 19.398438
| 22
| 0.766968
| 0.628906
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 9
| 108
| 7.699219
| 120
| 20
| 36.89844
| 390
| null | 0.399963
| 0.699951
| 143
| 7.219727
| null | null | null | 1
| 7
|
adl>=4 (>=5 if sur)
| 7
| 307
| 1
|
88.58899
|
female
| 0
| 17
|
COPD
|
COPD/CHF/Cirrhosis
| 2
| 12
| null | 0
| null | null | null | 14.666664
|
white
| 29.796875
| 45
| 0.380981
| 0.185974
| 10
| 0
| 0
|
no
| 0.5
| 0.5
|
dnr after sadm
| 3
| 69
| 13
| 64
| 35
| 34.79688
| 110.20312
| null | null | 1.199951
| 139
| 7.469727
| null | null | null | null | 0
|
SIP>=30
| 0
| 1,359
| 0
|
68.73395
|
male
| 1
| 6
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 7
|
$11-$25k
| 26
| 34,104.062
| 21,455.3281
| null | 47
|
white
| 40.195313
| 72
| 0.28894
| 0.178986
| 1
| 1
| 0
|
no
| 0.05
| 0.000125
|
no dnr
| 6
| 46
| 10.099609
| 160
| 40
| 39.09375
| 112
| 2.699707
| 0.099991
| 1.799805
| 143
| 7.589844
| null | null | null | null | null |
<2 mo. follow-up
| 2.38916
| 6
| 1
|
39.01398
|
female
| 0
| 10
|
Colon Cancer
|
Cancer
| 1
| 16
|
$25-$50k
| 0
| 15,749.195
| 9,910.6797
| null | 13.5
|
hispanic
| 12.898438
| 5
| 0.896973
| 0.763916
| 1
| 0
| 0
|
metastatic
| 0.8
| 0.5
|
no dnr
| 10
| 85
| 9.398438
| 76
| 20
| 36.29688
| null | 3.799805
| 0.599976
| 0.599976
| 142
| null | null | null | null | 1
| null |
no(M2 and SIP pres)
| 1.1669
| 552
| 1
|
72.62695
|
male
| 0
| 48
|
Coma
|
Coma
| 0
| 6
|
under $11k
| 61
| 114,186.188
| 77,824.25
| null | 24
|
white
| 21.296875
| 17
| 0.317993
| 0.246979
| 7
| 0
| 0
|
no
| 0.6
| 0.55
|
no dnr
| 48
| 109
| 17.199219
| 56
| 28
| 37.5
| 316.625
| null | null | 0.799927
| 131
| 7.429688
| null | null | null | null | 1
|
adl>=4 (>=5 if sur)
| 1
| 1,358
| 0
|
65.32794
|
male
| 0
| 5
|
Lung Cancer
|
Cancer
| 1
| 17
|
>$50k
| 0
| 6,116.098
| 3,664.3906
| null | 10
|
white
| 14.699219
| 15
| 0.750977
| 0.490967
| 1
| 0
| 0
|
metastatic
| null | null |
no dnr
| 5
| 100
| 10
| 64
| 20
| 36.69531
| null | null | 0.5
| 1
| 139
| null | null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 307
| 1
|
33.16898
|
male
| 0
| 24
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 2
| null | null | 0
| 49,249.938
| 31,747.3594
| null | 18.333328
|
white
| 34.296875
| 50
| 0.695923
| 0.530884
| 2
| 0
| 0
|
no
| 0.8
| 0.8
|
no dnr
| 24
| 44
| 5.399414
| 120
| 27
| 36.5
| 480.9375
| 2.5
| 1.199951
| 2.199707
| 141
| 7.449219
| null | null | null | 0
| null |
no(M2 and SIP pres)
| 0.4948
| 1,355
| 0
|
72.70398
|
male
| 0
| 21
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 4
| null | 0
| 49,507.219
| 33,661.8125
| null | 26.333328
|
white
| 29
| 37
| 0.621948
| 0.517944
| 1
| 0
| 0
|
yes
| 0.3
| 0.15
|
dnr after sadm
| 10
| 132
| 21.796875
| 126
| 23
| 38.69531
| 110
| 2.299805
| 0.299988
| 0.699951
| 133
| 7.429688
| null | null | null | null | 0
|
no(M2 and SIP pres)
| 0
| 207
| 1
|
63.27399
|
female
| 0
| 5
|
Lung Cancer
|
Cancer
| 1
| 10
|
$25-$50k
| 0
| 5,416.098
| 3,314.0606
| null | 8
|
white
| 16.199219
| 15
| 0.727905
| 0.454956
| 1
| 0
| 0
|
metastatic
| null | null |
no dnr
| 5
| 96
| 11.898438
| 76
| 28
| 37.39844
| null | null | 0.299988
| 0.699951
| 141
| null | null | null | null | 1
| 1
|
no(M2 and SIP pres)
| 1
| 201
| 1
|
23.85199
|
male
| 1
| 7
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 12
|
$11-$25k
| 100
| 67,589.312
| 43,827.4062
| null | 39
|
black
| 36.398438
| 68
| 0.268982
| 0.161987
| 4
| 0
| 0
|
no
| 0.2
| 0.1
|
no dnr
| 7
| 127
| 8.898438
| 160
| 36
| 35.39844
| 404
| null | 13.599609
| 1.399902
| 161
| 7.509766
| null | null | null | null | 1
|
<2 mo. follow-up
| 1
| 7
| 1
|
65.79297
|
male
| 0
| 4
|
Lung Cancer
|
Cancer
| 1
| 12
|
$11-$25k
| 0
| 5,295.699
| 3,165.8652
| null | 16
|
white
| 16.796875
| 22
| 0.710938
| 0.429993
| 1
| 0
| 0
|
metastatic
| 0.9
| 0.5
|
no dnr
| 4
| 77
| 21.199219
| 84
| 24
| 37.59375
| null | null | 0.699951
| 1.199951
| 132
| null | null | null | null | null | null |
<2 mo. follow-up
| 2.015625
| 31
| 1
|
76.18097
|
female
| 0
| 6
|
Colon Cancer
|
Cancer
| 1
| 13
|
under $11k
| 0
| 5,235.797
| 3,665.3242
| null | 10
|
white
| 16.5
| 15
| 0.803955
| 0.581909
| 1
| 0
| 0
|
metastatic
| null | null |
no dnr
| 6
| 100
| 3.099609
| 68
| 20
| 36.79688
| null | 3.299805
| 0.299988
| 0.799927
| 143
| null | null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 1,350
| 0
|
53.13898
|
male
| 0
| 6
|
Lung Cancer
|
Cancer
| 1
| 12
| null | 0
| 3,427.949
| 2,561.9609
| null | 9
|
white
| 20.199219
| 13
| 0.671997
| 0.373962
| 1
| 0
| 0
|
metastatic
| 1
| 1
|
no dnr
| 6
| 110
| 9.898438
| 100
| 20
| 36.79688
| null | null | null | 0.399963
| 136
| null | null | null | null | 0
| 5
|
no(M2 and SIP pres)
| 5
| 376
| 1
|
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.